For patients with hepatitis C virus (HCV) infection who respond rapidly to peginterferon-α-2a, 8 weeks of therapy is as effective as a 24 weeks

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1639, 2008-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon-α2a for the treatment of hepatitis B infection

By Cooksley W Graham E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1373-1380

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon-α2a in the treatment of chronic hepatitis C

By Akimov Sergey   Adeyemi Oluwatoyin M  

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 689-701

Future Medicine

Access to resources Recommend Favorite

Peginterferon-α-2a and 2b good value for HCV infection

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b: Autoimmune hepatitis in a patient with chronic hepatitis C virus and HIV infections: case report

By  

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b: highs and lows in chronic HCV infection

By  

Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite